Glenmede Trust’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Sell
54,523
-6,125
-10% -$3.1M 0.12% 141
2025
Q4
$34.3M Buy
+60,648
New +$32.3M 0.16% 113
2025
Q1
$25.6M Sell
51,772
-2,963
-5% -$1.64M 0.14% 138
2024
Q4
$28.6M Buy
54,735
+1,170
+2% +$609K 0.15% 131
2024
Q3
$26.3M Buy
53,565
+2,655
+5% +$1.24M 0.13% 162
2024
Q2
$22.6M Sell
50,910
-1,692
-3% -$674K 0.11% 175
2024
Q1
$21M Buy
52,602
+1,986
+4% +$750K 0.11% 193
2023
Q4
$17.1M Sell
50,616
-6,347
-11% -$1.89M 0.09% 229
2023
Q3
$16.6M Buy
56,963
+9,845
+21% +$3.07M 0.1% 219
2023
Q2
$12M Hold
47,118
0.07% 299
2023
Q1
$12M Buy
47,118
+30,035
+176% +$7.4M 0.07% 300
2022
Q4
$4.53M Sell
17,083
-229
-1% -$55.8K 0.03% 423
2022
Q3
$3.24M Sell
17,312
-20,759
-55% -$4.46M 0.02% 442
2022
Q2
$7.64M Sell
38,071
-39
-0.1% -$9.15K 0.04% 375
2022
Q1
$11.5M Buy
38,110
+1,965
+5% +$574K 0.06% 356
2021
Q4
$13M Buy
36,145
+2,578
+8% +$887K 0.06% 343
2021
Q3
$11.1M Sell
33,567
-1,410
-4% -$473K 0.06% 343
2021
Q2
$10.7M Buy
34,977
+297
+0.9% +$83.3K 0.06% 339
2021
Q1
$8.54M Buy
34,680
+735
+2% +$185K 0.05% 342
2020
Q4
$9.26M Buy
33,945
+927
+3% +$230K 0.05% 333
2020
Q3
$7.81M Buy
33,018
+26,544
+410% +$5.96M 0.05% 333
2020
Q2
$1.23M Buy
6,474
+354
+6% +$63.5K 0.01% 568
2020
Q1
$1.21M Hold
6,120
0.01% 715
2019
Q4
$1.21M Sell
6,120
-57
-0.9% -$10.7K 0.01% 715
2019
Q3
$1.11K Sell
6,177
-756
-11% -$131K 0.01% 716
2019
Q2
$1.21K Buy
6,933
+33
+0.5% +$5.65K 0.01% 714
2019
Q1
$1.31K Buy
6,900
+2,379
+53% +$423K 0.01% 698
2018
Q4
$720 Sell
4,521
-474
-9% -$80.3K ﹤0.01% 784
2018
Q3
$955K Sell
4,995
-57
-1% -$10.1K ﹤0.01% 757
2018
Q2
$806K Sell
5,052
-20,793
-80% -$3.17M ﹤0.01% 750
2018
Q1
$3.14M Hold
25,845
0.01% 573
2017
Q4
$3.14M Buy
25,845
+1,068
+4% +$134K 0.01% 573
2017
Q3
$2.88M Buy
24,777
+1,188
+5% +$129K 0.01% 585
2017
Q2
$2.01M Hold
23,589
0.01% 641
2017
Q1
$2.01M Buy
23,589
+19,818
+526% +$1.57M 0.01% 641
2016
Q4
$265K Buy
3,771
+1,296
+52% +$95.3K ﹤0.01% 1134
2016
Q3
$198K Hold
2,475
﹤0.01% 1197
2016
Q2
$181K Buy
2,475
+72
+3% +$5.07K ﹤0.01% 1201
2016
Q1
$159K Hold
2,403
﹤0.01% 1221
2015
Q4
$145K Sell
2,403
-1,080
-31% -$60.7K ﹤0.01% 1260
2015
Q3
$177K Buy
3,483
+126
+4% +$7.14K ﹤0.01% 1205
2015
Q2
$179K Sell
3,357
-1,683
-33% -$94.2K ﹤0.01% 1255
2015
Q1
$282K Sell
5,040
-1,278
-20% -$72.3K ﹤0.01% 1151
2014
Q4
$370K Buy
6,318
+657
+12% +$36.6K ﹤0.01% 1076
2014
Q3
$290K Sell
5,661
-135
-2% -$6.7K ﹤0.01% 1066
2014
Q2
$264K Buy
5,796
+3,870
+201% +$171K ﹤0.01% 1079
2014
Q1
$92K Sell
1,926
-3,960
-67% -$187K ﹤0.01% 1447
2013
Q4
$250K Hold
5,886
﹤0.01% 1073
2013
Q3
$245K Sell
5,886
-23,265
-80% -$1.03M ﹤0.01% 1058
2013
Q2
$1.64M Buy
+29,151
New +$1.61M 0.02% 537

Other funds holding ISRG

Glenmede Trust's ISRG Position: Q1 2026 in Review

Glenmede Trust reduced its Intuitive Surgical (ISRG) stake by 10% in Q1 2026, selling an estimated $3.1M and leaving 54,523 shares worth $25.1M. The position accounts for 0.12% of the portfolio, ranked #141.

Glenmede Trust first reported a position in ISRG in Q2 2013 and has held it in 50 quarters since. The position peaked at $34.3M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Glenmede Trust held 54,523 shares of Intuitive Surgical worth $25.1M as of Q1 2026.
  • Glenmede Trust sold 6,125 Intuitive Surgical shares in Q1 2026, an estimated $3.1M.
  • Intuitive Surgical made up 0.12% of Glenmede Trust's portfolio in Q1 2026, its #141 holding.
  • Glenmede Trust first reported a position in Intuitive Surgical in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Intuitive Surgical position peaked at $34.3M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.